Search
Keros Therapeutics Inc
KROSAdd to Watchlist
11.260USD
+0.380+3.49%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
220.06MMarket Cap
LossP/E TTM
Keros Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
244.06M
6774.96%
EPS(YoY)
2.34
146.71%
Analyst Rating
BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Keros Therapeutics Inc?
According to Keros Therapeutics Inc's FY2025 earnings report, its total revenue reached 244.06M, with a year-on-year change of 6774.96.
What are the current assets of Keros Therapeutics Inc?
According to Keros Therapeutics Inc's FY2025 earnings report, its current assets were 315.43M, with a year-on-year change of -46.44.
What are the total assets of Keros Therapeutics Inc?
According to Keros Therapeutics Inc's FY2025 earnings report, its total assets of Keros Therapeutics Inc were 338.02M, with a year-on-year change of -45.12.
What are the total liabilities of Keros Therapeutics Inc?
According to Keros Therapeutics Inc's FY2025 earnings report, its total liabilities of Keros Therapeutics Inc were 34.89M, with a year-on-year change of -21.30.
What is the total equity of Keros Therapeutics Inc?
According to Keros Therapeutics Inc's FY2025 earnings report, its total equity of Keros Therapeutics Inc was 303.13M, with a year-on-year change of -46.96.
What is the net investment of Keros Therapeutics Inc?
According to Keros Therapeutics Inc's FY2025 earnings report, its net investment of Keros Therapeutics Inc was -1.55M, with a year-on-year change of 19.68.
What is the net financing of Keros Therapeutics Inc?
According to Keros Therapeutics Inc's FY2025 earnings report, its net financing of Keros Therapeutics Inc was -378.47M, with a year-on-year change of -196.59.
What is the Earnings Per Share (EPS) of Keros Therapeutics Inc?
According to Keros Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 2.34, with a year-on-year change of 146.71.
What is the net margin of Keros Therapeutics Inc?
According to Keros Therapeutics Inc's FY2025 earnings report, its net profit margin was 35.65, with a year-on-year change of 100.68.
What is the Return on Equity (ROE) of Keros Therapeutics Inc?
According to Keros Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was 19.90, with a year-on-year change of 147.99.
What is the Return on Assets (ROA) of Keros Therapeutics Inc?
According to Keros Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was 18.24, with a year-on-year change of 148.00.
What is the operating profit of Keros Therapeutics Inc?
According to Keros Therapeutics Inc's FY2025 earnings report, its operating profit was 70.67M, with a year-on-year change of 133.52.